| Date Filed | Type | Description |
| 10/12/2023 |
8-K
| Quarterly results |
| 10/04/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 10/03/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 50 options to buy
@ $149.06, valued at
$7.5k
|
|
| 10/03/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 259 options to buy
@ $149.06, valued at
$38.6k
|
|
| 09/27/2023 |
4
| GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Gifted 42,000 shares
@ $0 |
|
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
4
| GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 18,500 shares
@ $149.15, valued at
$2.8M
Sold 60,000 shares
@ $148.58, valued at
$8.9M
|
|
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/10/2023 |
3
| Donoghoe Nicholas (EVP, Chief Bus/Strat Officer) has filed a Form 3 on AbbVie Inc. |
| 07/06/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 07/05/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 287 options to buy
@ $134.73, valued at
$38.7k
|
|
| 07/05/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 55 options to buy
@ $134.73, valued at
$7.4k
|
|
| 06/29/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/28/2023 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 06/09/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/12/2023 |
4
| Strom Carrie C (SVP & PRES GLOBAL ALLERG AESTH) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 2,876 shares
@ $146.42, valued at
$421.1k
|
|
| 05/10/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/09/2023 |
4
| WADDELL FREDERICK H (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| TILTON GLENN F (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| Roberts Rebecca B (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| MEYER MELODY B (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| Hart Brett J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| AUSTIN ROXANNE S (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4/A
| AUSTIN ROXANNE S (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 6,222 shares
@ $150.5, valued at
$936.4k
|
|
| 05/09/2023 |
4
| BURNSIDE WILLIAM H.L. (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/09/2023 |
4
| Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 1,450 shares
@ $0 |
|
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
PX14A6G
| Form PX14A6G - Notice of exempt solicitation submitted by non-management: |
|